适体
指数富集配体系统进化
2019年冠状病毒病(COVID-19)
计算生物学
抗病毒药物
药物开发
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
鉴定(生物学)
生物
病毒
病毒学
药品
医学
传染病(医学专业)
药理学
疾病
核糖核酸
遗传学
病理
植物
基因
作者
Zhuoer Chen,Qi Sun,Ying Yang,Xunqing Nie,Wenyu Xiang,Yueyang Ren,Tao Le
标识
DOI:10.1016/j.ijbiomac.2023.128677
摘要
Animal diseases often have significant consequences due to the unclear and time-consuming diagnosis process. Furthermore, the emergence of new viral infections and drug-resistant pathogens has further complicated the diagnosis and treatment of viral diseases. Aptamers, which are obtained through systematic evolution of ligands by exponential enrichment (SELEX) technology, provide a promising solution as they enable specific identification and binding to targets, facilitating pathogen detection and the development of novel therapeutics. This review presented an overview of aptasensors for animal virus detection, discussed the antiviral activity and mechanisms of aptamers, and highlighted advancements in aptamer-based antiviral research following the COVID-19 pandemic. Additionally, the challenges and prospects of aptamer-based virus diagnosis and treatment research were explored. Although this review was not exhaustive, it offered valuable insights into the progress of aptamer-based antiviral drug research, target mechanisms, as well as the development of novel antiviral drugs and biosensors.
科研通智能强力驱动
Strongly Powered by AbleSci AI